Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity.

• Published in: PLOS Neglected Tropical Diseases
• Main Authors: Ji-Hoon Park, Min-Hee Kim, Edwin Sutanto, Seok-Won Na, Min-Jae Kim, Joon Sup Yeom, Myat Htut Nyunt, Mohammed Mohieldien Abbas Elfaki, Muzamil Mahdi Abdel Hamid, Seok Ho Cha, Sisay Getachew Alemu, Kanlaya Sriprawat, Nicholas M Anstey, Matthew J Grigg, Bridget E Barber, Timothy William, Qi Gao, Yaobao Liu, Richard D Pearson, Ric N Price, Francois Nosten, Sung-Il Yoon, Joo Hwan No, Eun-Taek Han, Sarah Auburn, Bruce Russell, Jin-Hee Han
• Format: Article in Journal/Newspaper
• Language: English
• Published: Public Library of Science (PLoS) 2022
• Subjects: Arctic medicine. Tropical medicine; RC955-962; Public aspects of medicine; RA1-1270; Arctic; Random Point
• Online Access: https://doi.org/10.1371/journal.pntd.0010492; https://doaj.org/article/3436a76552fa4fde89759ad3b0038c8a

Plasmodium vivax is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease. P. vivax reticulocyte binding protein 1a (PvRBP1a) is...